Pictet Asset Management Holding SA Has $57.01 Million Stock Position in HCA Healthcare, Inc. $HCA

Pictet Asset Management Holding SA reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 12.0% during the 4th quarter, HoldingsChannel.com reports. The firm owned 122,067 shares of the company’s stock after selling 16,605 shares during the period. Pictet Asset Management Holding SA’s holdings in HCA Healthcare were worth $57,013,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Palisade Asset Management LLC bought a new stake in shares of HCA Healthcare during the 3rd quarter worth $26,000. Holos Integrated Wealth LLC bought a new stake in shares of HCA Healthcare during the 4th quarter worth $29,000. Harbor Capital Advisors Inc. lifted its position in shares of HCA Healthcare by 82.9% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock worth $32,000 after buying an additional 34 shares during the last quarter. JPL Wealth Management LLC bought a new stake in shares of HCA Healthcare during the 3rd quarter worth $33,000. Finally, Aventura Private Wealth LLC bought a new stake in shares of HCA Healthcare during the 4th quarter worth $34,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Stockholders reaffirmed HCA’s board and governance at the April 23 annual meeting — removes near?term activist/governance uncertainty and supports continuity of management strategy. HCA Healthcare Stockholders Reaffirm Board and Governance Structure
• Positive Sentiment: Management highlights improvements in revenue?cycle performance (CFO commentary) that are contributing to margin resilience despite rising denials/underpayments — a constructive operating tailwind. HCA’s strengthened revenue cycle paying dividends, CFO says
• Neutral Sentiment: Company announced a proposed public offering of senior notes — proceeds for general corporate purposes and possible refinancing; watch pricing and size for balance?sheet/interest?cost implications. HCA Announces Proposed Public Offering of Senior Notes
• Neutral Sentiment: Local operational news: new $231M Florida hospital opening in May and a Gulf Coast NICU reunion — positive for regional capacity/brand but not material near?term drivers. $231M HCA Florida hospital to open in May HCA Gulf Coast Hospital NICU reunion for patients & families
• Neutral Sentiment: Executive hire: Cynthia Cifuentes?Finkel named SVP of Marketing & Corporate Affairs (effective June 8) — supports communications/brand, immaterial to near?term financials. HCA Healthcare Names Cynthia Cifuentes?Finkel SVP
• Negative Sentiment: Analysts across the street cut price targets after Q1: multiple firms lowered PTs (examples: Bernstein to $503, Oppenheimer to $520, TD Cowen/Leerink to ~$500, RBC/Truist/Stephens also trimmed). The volume of PT trims amplifies downward pressure on the stock despite several banks keeping Buy/Outperform stances. Bernstein adjusts price target on HCA
• Negative Sentiment: Policy/revenue hit: the lapse in ACA subsidy funding reduced Q1 results by about $150M — a tangible near?term earnings drag referenced in coverage. ACA subsidy lapse cost HCA Healthcare $150M in Q1
• Negative Sentiment: Analysts trimmed forward forecasts after Q1 in several writeups (sales roughly in line but EPS slightly missed), increasing near?term uncertainty around estimates and supporting the sell?side PT resets. These Analysts Slash Their Forecasts On HCA Healthcare After Q1 Results

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on HCA shares. Oppenheimer dropped their price objective on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a research report on Monday. Deutsche Bank Aktiengesellschaft reduced their price target on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a research report on Tuesday. Argus boosted their price objective on HCA Healthcare from $530.00 to $560.00 and gave the company a “buy” rating in a research note on Friday, February 6th. JPMorgan Chase & Co. upped their target price on HCA Healthcare from $420.00 to $535.00 and gave the company a “neutral” rating in a research report on Friday, February 20th. Finally, Leerink Partners decreased their target price on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research report on Monday. Sixteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $520.55.

Insider Activity at HCA Healthcare

In related news, SVP Jennifer Berres sold 8,020 shares of the firm’s stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total value of $4,126,931.60. Following the completion of the transaction, the senior vice president directly owned 11,993 shares of the company’s stock, valued at approximately $6,171,357.94. This trade represents a 40.07% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Christopher F. Wyatt sold 4,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the completion of the transaction, the senior vice president directly owned 44,379 shares of the company’s stock, valued at approximately $22,411,395. This trade represents a 8.27% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 15,214 shares of company stock worth $7,797,595. 1.50% of the stock is currently owned by company insiders.

HCA Healthcare Stock Down 3.3%

HCA Healthcare stock opened at $430.99 on Wednesday. HCA Healthcare, Inc. has a 52 week low of $329.72 and a 52 week high of $556.52. The company’s 50 day moving average price is $501.51 and its two-hundred day moving average price is $486.12. The stock has a market cap of $96.36 billion, a P/E ratio of 14.82, a P/E/G ratio of 1.50 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. During the same period in the prior year, the business earned $6.45 EPS. HCA Healthcare’s quarterly revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 30.06 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.73%.

HCA Healthcare Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.